Savior Lifetec - Asset Resilience Ratio

Latest as of December 2025: 18.86%

Savior Lifetec (4167) has an Asset Resilience Ratio of 18.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$789.00 Million

≈ $24.86 Million USD Cash + Short-term Investments

Total Assets

NT$4.18 Billion

≈ $131.82 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Savior Lifetec's Asset Resilience Ratio has changed over time. Check how strategically is Savior Lifetec's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Savior Lifetec's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Savior Lifetec.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$789.00 Million	18.86%
Total Liquid Assets	NT$789.00 Million	18.86%

Asset Resilience Insights

Good Liquidity Position: Savior Lifetec maintains a healthy 18.86% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Savior Lifetec Industry Peers by Asset Resilience Ratio

Compare Savior Lifetec's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for Savior Lifetec (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Savior Lifetec.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	18.86%	NT$789.00 Million ≈ $24.86 Million	NT$4.18 Billion ≈ $131.82 Million	+1.47pp
2024-12-31	17.39%	NT$761.06 Million ≈ $23.98 Million	NT$4.38 Billion ≈ $137.87 Million	+10.74pp
2023-12-31	6.65%	NT$254.27 Million ≈ $8.01 Million	NT$3.82 Billion ≈ $120.44 Million	-6.14pp
2022-12-31	12.79%	NT$563.76 Million ≈ $17.76 Million	NT$4.41 Billion ≈ $138.90 Million	+12.44pp
2021-12-31	0.35%	NT$15.71 Million ≈ $495.01K	NT$4.54 Billion ≈ $142.99 Million	-2.13pp
2020-12-31	2.47%	NT$119.65 Million ≈ $3.77 Million	NT$4.84 Billion ≈ $152.38 Million	+1.88pp
2019-12-31	0.60%	NT$24.13 Million ≈ $760.13K	NT$4.03 Billion ≈ $127.07 Million	-1.60pp
2018-12-31	2.19%	NT$77.42 Million ≈ $2.44 Million	NT$3.53 Billion ≈ $111.20 Million	+2.18pp
2017-12-31	0.01%	NT$420.00K ≈ $13.23K	NT$3.95 Billion ≈ $124.37 Million	--

pp = percentage points

About Savior Lifetec

TWO:4167 Taiwan Biotechnology

Market Cap

$165.29 Million

NT$5.25 Billion TWD

Market Cap Rank

#17215 Global

#846 in Taiwan

Share Price

NT$16.90

Change (1 day)

+1.20%

52-Week Range

NT$16.70 - NT$21.85

All Time High

NT$40.63